Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
George Mason University Constructs National Center for Biodefense and Infectious Diseases
The National Institutes of Health's National Institute of Allergy and Infectious Diseases has awarded George Mason University (GMU) a $25-million grant to construct a new BSL-3 biocontainment laboratory in Fairfax, Va. The facility will be part of GMU's $45-million National Center for Biodefense and Infectious Diseases, an 83,000-sf facility that will accommodate research on diseases considered to be potential bioterror threats.
Wyeth Opens Biotech Production Facility in Ireland
Wyeth Pharmaceuticals opened its 1.2 million-sf Grange Castle biotech production facility on September 8, 2005. Located in South County Dublin, Ireland, the $2 billion project began site work in October of 2002. Employing over 1,000 workers, the facility is comprised of three separate buildings: a drug development unit, a drug substance site, and a drug product facility. Production will begin on a phased basis over the next four years.
University of Massachusetts Dartmouth Breaks Ground on Botulism Research Center
The University of Massachusetts Dartmouth broke ground in September 2005 on a $9-million, 20,000-sf research center dedicated to the study of botulism, a potential bioterrorism threat.
University of Hawaii Constructs Biodefense Laboratory
The University of Hawaii has been awarded a $25 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to construct a new biodefense laboratory in Pearl City. The BSL-3 facility will be sited near the existing state Department of Health laboratory and may receive additional funding from a proposed $12 million state grant. Construction of the new biocontainment laboratory is slated to begin in fall 2006.
UMDNJ Completes $72 Million Child Health Institute
The University of Medicine and Dentistry of New Jersey (UMDNJ) has completed construction of the 145,000-sf Child Health Institute in New Brunswick, N.J. Part of the Robert Wood Johnson Medical School of UMDNJ, the $72 million facility was developed in partnership with the New Brunswick Development Corporation. Designed by Princeton-based The Hillier Group, the comprehensive biomedical research center will accommodate research on the prevention, treatment and cure of childhood diseases with an emphasis on translational medicine.